Welsh, Carson, Anderson & Stowe Leads Growth Investment in LINQ

Welsh, Carson, Anderson & Stowe Acquires Majority Stake in EquiLend

January 18, 2024

Financial Services

Welsh, Carson, Anderson & Stowe (WCAS) has completed its majority acquisition of EquiLend, a global financial technology, data and analytics provider for the securities finance industry, following regulatory approvals in the U.S., UK and Ireland. Founding shareholders and customers — including Bank of America, BlackRock, Goldman Sachs, Morgan Stanley, National Bank of Canada, State Street and UBS — joined WCAS as owners; WCAS previously committed $200 million to support EquiLend's organic growth and acquisitions.

Welsh, Carson, Anderson & Stowe Acquires Majority Stake in GovernmentCIO

November 2, 2020

IT Services

Welsh, Carson, Anderson & Stowe (WCAS) completed a strategic majority investment in GovernmentCIO, a provider of technology and digital solutions to the federal health IT market. The investment will fund organic growth and support a buy-and-build strategy to expand GovernmentCIO’s capabilities and customer footprint across federal health and adjacent federal IT markets.

Welsh, Carson, Anderson & Stowe Makes Strategic Growth Investment in ImageTrend, Inc.

February 10, 2023

Software

Welsh, Carson, Anderson & Stowe (WCAS) made an equity growth investment in ImageTrend, Inc., a market-leading provider of public safety and healthcare software, to accelerate growth and product innovation. WCAS partners with ImageTrend’s management and will add investment team members to the board to support continued expansion of the company’s software, analytics, and services across EMS, hospitals, fire, and public safety end markets.

Welsh, Carson, Anderson & Stowe Acquires Green Street Advisors from Golden Gate Capital

June 3, 2019

Data & Analytics

Welsh, Carson, Anderson & Stowe (WCAS) has signed a definitive agreement to acquire Green Street Advisors from Golden Gate Capital. Management will reinvest and WCAS plans to accelerate organic growth, invest in product innovation and pursue strategic M&A to expand Green Street's research, data and analytics offerings for the commercial real estate market.

Welsh, Carson, Anderson & Stowe Commits $250M to Kiniciti Platform for Cell & Gene Therapy Ecosystem

February 1, 2021

Biotechnology

Welsh, Carson, Anderson & Stowe (WCAS) committed up to $250 million to a strategic partnership with newly-formed Kiniciti, a platform that will invest in non-therapeutic companies supporting the cell and gene therapy ecosystem. The capital will support Kiniciti's flexible investment model (control, growth equity and significant minority stakes) to scale companies that provide process, production, materials and delivery capabilities for CGT.

Welsh, Carson, Anderson & Stowe and Walgreen Co. Invest in Shields Health Solutions

July 31, 2019

Healthcare Services

Welsh, Carson, Anderson & Stowe (WCAS) and Walgreen Co. (Walgreens) made undisclosed equity investments in Shields Health Solutions to support the company’s national expansion and growth of its integrated specialty pharmacy model. The capital will help Shields expand into new disease states and enhance integrated service and technology offerings while accelerating partnerships with health systems nationwide.